Lixte Biotechnology Holdings, Inc. LIXT
Last Post: 10/16/2023 1:26:00 PM
Board Marks: 0
Posts Today: 0
Board Views Today: 35
Post
Subject
Author
Posted On
Recent Articles
- Xi Jinping Supports Hong Kong's Economic Strategies and Development
- Solar Alliance Energy Gains Shareholder Approval in Key Meeting
- Fruit Street Health Enhances Diabetes Prevention with Meals
- CNOOC Limited Partners with INEOS Energy in New Agreement
- Exciting Collaboration: Celebrate Japan's Fruit Culture
- Investors Urged to Act Before Deadline in Xiao-I Class Action
- Karma Sauce Applauds First We Feast's Bold New Direction
- Cassava Sciences Investors Encouraged to Act on Stock Losses
- Investors Warned of Upcoming Deadline in WM Technology Case
- Investors Urged to Act: Acadia Healthcare Class Action Deadline
- Aehr Test Systems Faces Class Action, Investors Urged to Act Soon
- Investors Alert: Upcoming Lead Plaintiff Motion Deadline for CUBI
- Legal Action Announced for Five9, Inc. Investors Following Stock Decline
- Legal Action Launched for Kyverna Therapeutics Investors
- Everlight Solar's Culture: A Testament to Team Camaraderie and Growth
- Haloid Enhances Safety in Film Productions with Reviews
- Insights on the Growing Demand for Edible Coatings in Produce
- Prospect Ridge Resources Adjusts Plans for Upcoming Meeting
- Legal Update: Toronto-Dominion Bank Securities Class Action
- Key Updates from Nasdaq on the Nasdaq-100 Index Changes
- TeraBox Revolutionizes File Sharing with Free Unlimited Service
- Kessler Topaz Takes Action Against Enphase Energy for Fraud
- Demesne Resources Completes Second Tranche of Financing
- Spiro Celebrated as One of the Top Agencies in Marketing
- Global Uranium Corp. Launches Strategic Marketing Efforts
- UnitedHealth Group Clarifies Misconceptions and Updates Claims
- Neurocrine Biosciences Unveils Potential of CRENESSITY™ for CAH
- Acadia Healthcare Investors Urged to Take Action on Lawsuit
- Global Uranium Corp. Unveils C$1.5 Million Flow-Through Offering
- Rakovina Therapeutics Secures $3M to Propel Cancer Therapy Advances
- Hola Prime's Innovative Vision: New Marketing Director Appointed
- Teamsters Advocate for Stronger Standards on Autonomous Vehicles
- BioVaxys Secures Funding and Enters Debt Settlement Agreement
- Exciting Advancement as UNLOXCYT Gains FDA Approval for Treatment
- OFS Credit Company Shares November Net Asset Value Insights
- New FDA Approval for Crenessity Enhances CAH Treatment Options
- Q-Gold Secures Initial Funding for New Exploration Ventures
- Capital Power's Genesee Project Marks Major Energy Milestone
- Viridian Therapeutics Set to Present Veligrotug Results Soon
- Ensuring Safe Travels: King County's Holiday Traffic Initiative
- Acadia Healthcare Faces Class Action Amid Significant Losses
- S&P Dow Jones Indices Reveals Results of 2024 DJSI Review
- Celebrating Entrepreneurial Success: The Impact of MBDA
- Village Super Market's Dividend Announcement and Growth Plans
- Digi International Welcomes New Executive Leaders to Board
- Transfusion Market Expected to Rise by $2.6 Billion: Insights
- CenterPoint Energy Announces Increased Quarterly Dividend Payout
- Shobha Launches Exciting Offers and Convenient Memberships
- ANSC Secures Key Approval for Upcoming Business Combination
- Barite Market Forecast: Growth Driven by Oil and AI Trends